Perrigo downgraded to Sell from Neutral at Goldman Goldman downgraded Perrigoo due to valuation and expectations for slowing growth given the delayed Mucinex launch and new baby store brand formula packaging. Price target is $110.
Perrigo investor sentiment could improve this year, says Deutsche Bank Deutsche Bank believes Perrigo investor sentiment remains poor and says it "wouldn't wait for things to look perfect" to buy the stock. Deutsche thinks a return to consistent financial results, earnings growth acceleration in Q2 following the close of the Omega acquisition, and a possible investor day around May 5 could drive improved sentiment on the name. It lowered its price target for Perrigo shares to $200 from $204 and keeps a Buy rating on the stock.